/Companies

Science 37

Founded 2014 · 293 employees on LinkedIn · 9 known investors

Find your way into Science 37

Each arrow is one introduction. Sign up to fill in the first one.

269 people can intro you to Tyler

Ask Cris De Luca to introduce you to Tyler Van Horn

You →Cris · together at Science 37 →Tyler

Sign up to find every way you can get introduced to Science 37

  • Your email: who you already know at Science 37, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Science 37 team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Science37 operates a decentralized clinical trial platform supported by a network of medical directors across specialties including cardiology, neurology, psychiatry, pediatrics, and internal medicine. The company serves the clinical research and pharmaceutical industry.

Founders & leadership

TVTyler Van Horn
Tyler Van HornChief Executive OfficerTyler Van Horn is Chief Executive Officer of Science37, a decentralized clinical trial platform. He holds an MBA from a top-15 business school and has held executive positions at life sciences companies.
DWDebra Weinstein
Debra WeinsteinChief Medical Officer

Investors · 9

Also in the syndicate · 2

dRx CapitalSanofi Genzyme BioVentures

Funding

SEC filings, press & company announcements

$40M disclosed across 1 of 3 rounds · 2015–2020

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Science 37 went on to found or lead other companies.

Related companies · 2

Companies working in the same space as Science 37.

In the news

Frequently asked questions

What does Science 37 do?
Science37 operates a decentralized clinical trial platform supported by a network of medical directors across specialties including cardiology, neurology, psychiatry, pediatrics, and internal medicine. The company serves the clinical research and pharmaceutical industry.
Who are Science 37's investors?
Science 37's investors include Glynn Capital Management, GV (Google Ventures), LifeSci Venture Partners, Lux Capital, Sanofi Ventures, Inertia Ventures, REDMILE.
How much funding has Science 37 raised?
Science 37 has disclosed $40M raised across 1 of its 3 known rounds.